200 related articles for article (PubMed ID: 21865577)
1. Magnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.
Kantarci K; Lowe V; Przybelski SA; Senjem ML; Weigand SD; Ivnik RJ; Roberts R; Geda YE; Boeve BF; Knopman DS; Petersen RC; Jack CR
Neurology; 2011 Sep; 77(10):951-8. PubMed ID: 21865577
[TBL] [Abstract][Full Text] [Related]
2. APOE modifies the association between Aβ load and cognition in cognitively normal older adults.
Kantarci K; Lowe V; Przybelski SA; Weigand SD; Senjem ML; Ivnik RJ; Preboske GM; Roberts R; Geda YE; Boeve BF; Knopman DS; Petersen RC; Jack CR
Neurology; 2012 Jan; 78(4):232-40. PubMed ID: 22189452
[TBL] [Abstract][Full Text] [Related]
3.
Nedelska Z; Przybelski SA; Lesnick TG; Schwarz CG; Lowe VJ; Machulda MM; Kremers WK; Mielke MM; Roberts RO; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neurology; 2017 Sep; 89(13):1391-1399. PubMed ID: 28842444
[TBL] [Abstract][Full Text] [Related]
4. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
Waldman AD; Rai GS
Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
[TBL] [Abstract][Full Text] [Related]
5. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
[TBL] [Abstract][Full Text] [Related]
6.
Kara F; Joers JM; Deelchand DK; Park YW; Przybelski SA; Lesnick TG; Senjem ML; Zeydan B; Knopman DS; Lowe VJ; Vemuri P; Mielke MM; Machulda MM; Jack CR; Petersen RC; Öz G; Kantarci K
Neurobiol Aging; 2022 Apr; 112():16-26. PubMed ID: 35038671
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography-guided magnetic resonance spectroscopy in Alzheimer disease.
Sheikh-Bahaei N; Sajjadi SA; Manavaki R; McLean M; O'Brien JT; Gillard JH
Ann Neurol; 2018 Apr; 83(4):771-778. PubMed ID: 29518282
[TBL] [Abstract][Full Text] [Related]
9. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.
Perrotin A; Mormino EC; Madison CM; Hayenga AO; Jagust WJ
Arch Neurol; 2012 Feb; 69(2):223-9. PubMed ID: 22332189
[TBL] [Abstract][Full Text] [Related]
10. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
Petrou M; Bohnen NI; Müller ML; Koeppe RA; Albin RL; Frey KA
Neurology; 2012 Sep; 79(11):1161-7. PubMed ID: 22933741
[TBL] [Abstract][Full Text] [Related]
11. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
Voevodskaya O; Poulakis K; Sundgren P; van Westen D; Palmqvist S; Wahlund LO; Stomrud E; Hansson O; Westman E;
Neurology; 2019 Jan; 92(5):e395-e405. PubMed ID: 30610093
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
13. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.
Zhao Y; Tudorascu DL; Lopez OL; Cohen AD; Mathis CA; Aizenstein HJ; Price JC; Kuller LH; Kamboh MI; DeKosky ST; Klunk WE; Snitz BE
JAMA Neurol; 2018 Jan; 75(1):88-96. PubMed ID: 29114732
[TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T.
Kantarci K; Reynolds G; Petersen RC; Boeve BF; Knopman DS; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Jack CR
AJNR Am J Neuroradiol; 2003 May; 24(5):843-9. PubMed ID: 12748083
[TBL] [Abstract][Full Text] [Related]
15. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.
Haley AP; Gonzales MM; Tarumi T; Miles SC; Goudarzi K; Tanaka H
Metab Brain Dis; 2010 Dec; 25(4):397-405. PubMed ID: 21063759
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy and cognitive function in healthy elderly men.
Ferguson KJ; MacLullich AM; Marshall I; Deary IJ; Starr JM; Seckl JR; Wardlaw JM
Brain; 2002 Dec; 125(Pt 12):2743-9. PubMed ID: 12429601
[TBL] [Abstract][Full Text] [Related]
18. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
[TBL] [Abstract][Full Text] [Related]
19. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study.
Pike KE; Ellis KA; Villemagne VL; Good N; Chételat G; Ames D; Szoeke C; Laws SM; Verdile G; Martins RN; Masters CL; Rowe CC
Neuropsychologia; 2011 Jul; 49(9):2384-90. PubMed ID: 21529702
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
